Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry. / Kononova, A. A.; Sokolova, A. S.; Cheresiz, S. V. и др.
в: MedChemComm, Том 8, № 12, 01.12.2017, стр. 2233-2237.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry
AU - Kononova, A. A.
AU - Sokolova, A. S.
AU - Cheresiz, S. V.
AU - Yarovaya, O. I.
AU - Nikitina, R. A.
AU - Chepurnov, A. A.
AU - Pokrovsky, A. G.
AU - Salakhutdinov, N. F.
N1 - Publisher Copyright: © 2017 The Royal Society of Chemistry.
PY - 2017/12/1
Y1 - 2017/12/1
N2 - There is currently no approved antiviral therapy for treatment of Marburg virus disease (MVD). Although filovirus infection outbreaks are quite rare, the high mortality rates in such outbreaks make the development of anti-filoviral drugs an important goal of medical chemistry and virology. Here, we performed screening of a large library of natural derivatives for their virus entry inhibition activity using pseudotype systems. The bornyl ester derivatives containing saturated N-heterocycles exhibited the highest antiviral activity. It is supposed that compounds with specific inhibitory activity toward MarV-GP-dependent virus entry will inhibit the rVSIV-ΔG-MarV-GP pseudotype much more efficiently than the control rVSIV-ΔG-G pseudotype. At the same time, the compounds similarly inhibiting both pseudotypes will likely affect rVSIV capsid replication or the cellular mechanisms common to the entry of both viruses. Borneol itself is not active against both pseudotypes and is nontoxic, whereas its derivatives have varying toxicity and antiviral activity. Among low-toxic borneol derivatives, six compounds turned out to be relatively specific inhibitors of MarV-GP-mediated infection (SC > 10). Of them, compound 6 containing a methylpiperidine moiety exhibited the highest virus-specific activity. Notably, the virus-specific activity of this compound is twice as high as that of the reference.
AB - There is currently no approved antiviral therapy for treatment of Marburg virus disease (MVD). Although filovirus infection outbreaks are quite rare, the high mortality rates in such outbreaks make the development of anti-filoviral drugs an important goal of medical chemistry and virology. Here, we performed screening of a large library of natural derivatives for their virus entry inhibition activity using pseudotype systems. The bornyl ester derivatives containing saturated N-heterocycles exhibited the highest antiviral activity. It is supposed that compounds with specific inhibitory activity toward MarV-GP-dependent virus entry will inhibit the rVSIV-ΔG-MarV-GP pseudotype much more efficiently than the control rVSIV-ΔG-G pseudotype. At the same time, the compounds similarly inhibiting both pseudotypes will likely affect rVSIV capsid replication or the cellular mechanisms common to the entry of both viruses. Borneol itself is not active against both pseudotypes and is nontoxic, whereas its derivatives have varying toxicity and antiviral activity. Among low-toxic borneol derivatives, six compounds turned out to be relatively specific inhibitors of MarV-GP-mediated infection (SC > 10). Of them, compound 6 containing a methylpiperidine moiety exhibited the highest virus-specific activity. Notably, the virus-specific activity of this compound is twice as high as that of the reference.
KW - ACID
KW - ANALGESIC ACTIVITY
KW - ANTIVIRAL DRUG DISCOVERY
KW - CELL ENTRY
KW - DISEASE
KW - EBOLA-VIRUS
KW - FILOVIRUS PROTEINS
KW - INFECTION
KW - METHOXY GROUPS
KW - MONOTERPENE MOIETIES
UR - http://www.scopus.com/inward/record.url?scp=85038566254&partnerID=8YFLogxK
U2 - 10.1039/c7md00424a
DO - 10.1039/c7md00424a
M3 - Article
C2 - 30108738
AN - SCOPUS:85038566254
VL - 8
SP - 2233
EP - 2237
JO - MedChemComm
JF - MedChemComm
SN - 2040-2503
IS - 12
ER -
ID: 9045637